Hikma delivers a resilient underlying performance in 2022 miscellaneous news Hikma delivers a resilient underlying performance in 2022 AETOSWire 23 February، 2023 Amman, Jordan — Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its preliminary... Read More Read more about Hikma delivers a resilient underlying performance in 2022